CS logo
small CS logo
Hospital Universitario de la Princesa; Servicio de Oncologia

Madrid, Spain
University hospital in Madrid
Calle de Diego de León, 62, 28006 Madrid
564 Beds

About Hospital Universitario de la Princesa; Servicio de Oncologia


The Hospital Universitario de la Princesa is a hospital located in the Lista neighborhood in Madrid, Spain, part of the hospital network of the Servicio Madrileño de Salud. It is one of the healthcare institutions associated to the Autonomous University of Madrid for the purpose of clinical internship.
There are 564 beds in Hospital Universitario de la Princesa; Servicio de Oncologia.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Hospital Universitario de la Princesa; Servicio de Oncologia


During the past decade, Hospital Universitario de la Princesa; Servicio de Oncologia conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators



Clinical Trials Conditions at Hospital Universitario de la Princesa; Servicio de Oncologia


According to Clinical.Site data, the most researched conditions in "Hospital Universitario de la Princesa; Servicio de Oncologia" are "Breast Cancer" (2 trials), "Colorectal Cancer" (1 trials) and "Non-Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Hospital Universitario de la Princesa; Servicio de Oncologia" in a lesser frequency.

Clinical Trials Intervention Types at Hospital Universitario de la Princesa; Servicio de Oncologia


Most popular intervention types in "Hospital Universitario de la Princesa; Servicio de Oncologia" are "Drug" (4 trials). Other intervention types were less common.
The name of intervention was led by "Paclitaxel" (2 trials), "5-Fluorouracil" (1 trials), "5-Fluorouracil (5-FU)" (1 trials), "Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody" (1 trials) and "Bevacizumab" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Hospital Universitario de la Princesa; Servicio de Oncologia


The vast majority of trials in "Hospital Universitario de la Princesa; Servicio de Oncologia" are 4 trials for "All" genders.

Clinical Trials Status at Hospital Universitario de la Princesa; Servicio de Oncologia


Currently, there are NaN active trials in "Hospital Universitario de la Princesa; Servicio de Oncologia". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Hospital Universitario de la Princesa; Servicio de Oncologia, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Hospital Universitario de la Princesa; Servicio de Oncologia, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".